Fortress Biotech (NASDAQ:FBIOP) Stock Price Down 0.1% – Should You Sell?

Fortress Biotech, Inc. (NASDAQ:FBIOP) was down 0.1% on Tuesday . The stock traded as low as $13.22 and last traded at $13.69. Approximately 27,491 shares traded hands during trading, a decline of 2% from the average daily volume of 28,084 shares. The stock had previously closed at $13.71.

Fortress Biotech Trading Down 1.2%

The business has a 50-day moving average of $12.49 and a two-hundred day moving average of $9.54.

About Fortress Biotech

Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.

The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.